Anika Therapeutics, Inc. - SIC # 3850 -

Ticker Exchange SIC # Website Latest Ticker
ANIK Nasdaq 3850 www.anika.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Anika Therapeutics, Inc.

Anika Therapeutics (ANIK) Stock Fair Value Rises After Q2 Beat And Higher Guidance - Aug 2nd, 2026 4:07 am
These 2 Biotech Stocks Hit New 52-Week Highs Today – And CORT Clocked Its Best Day In Nearly 16 Months - Jul 30th, 2026 11:53 am
Clarevia Ventures Welcomes Cheryl R. Blanchard, Ph.D., as Executive in Residence - Jul 30th, 2026 7:00 am
Anika Therapeutics Inc (ANIK) Q2 2026 Earnings Call Highlights: Record Revenue and Margin ... - Jul 29th, 2026 3:02 pm
Anika Therapeutics, Inc. Q2 2026 Earnings Call Summary - Jul 29th, 2026 1:16 pm
Anika Therapeutics Q2 Earnings Call Highlights - Jul 29th, 2026 8:04 am
Anika Reports Second Quarter 2026 Financial Results - Jul 29th, 2026 5:05 am
Anika to Issue Second Quarter 2026 Financial Results on Wednesday, July 29, 2026 - Jul 15th, 2026 2:01 pm
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jun 5th, 2026 3:00 pm
President of Anika Therapeutics Picks Up 51% More Stock - May 3rd, 2026 7:36 am
TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues - Apr 30th, 2026 2:43 pm
Anika Therapeutics, Inc. Q1 2026 Earnings Call Summary - Apr 29th, 2026 10:50 am
Anika Therapeutics Q1 Earnings Call Highlights - Apr 29th, 2026 8:20 am
Anika Reports First Quarter 2026 Financial Results - Apr 29th, 2026 5:05 am
Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.D. to its Board of Directors - Apr 16th, 2026 5:30 am
Anika to Issue First Quarter 2026 Financial Results on Wednesday, April 29, 2026 - Apr 15th, 2026 2:01 pm
Telix Strengthens Board with Additional Director Appointments - Apr 8th, 2026 4:44 pm
Revance CEO Nadeem Moiz on Expansion, Opportunities & Capitalization - Apr 7th, 2026 1:35 pm
Anika Therapeutics Touts $3B TAM, Cingal & Hyalofast Growth Plans at Canaccord MSK Conference - Mar 3rd, 2026 1:29 am
Anika Therapeutics, Inc. Q4 2025 Earnings Call Summary - Feb 27th, 2026 6:30 am